The role of bacteria in oral cancer

Indian Journal of Medical and Paediatric Oncology

Volumn 31, Issue 4, 2010, Pages 126-131

  Chocolatewala, Noureen ^a   Chaturvedi, Pankaj ^b   Desale, Rushikesh ^a  

^a MA Rangoonwala College of Dental Sciences and Research Center   (India)

^b TATA MEMORIAL HOSPITAL   (India)

Author keywords

Bacteria; carcinogenesis; oral squamous cell carcinoma

Indexed keywords

CYCLIN D1; MITOGEN ACTIVATED PROTEIN KINASE; PROTEIN BCL 2; RETINOBLASTOMA PROTEIN;

BACTERIUM; CANCER PATIENT; CANCER PREVENTION; CANCER SCREENING; CANCER TISSUE; CAPNOCYTOPHAGA GINGIVALIS; CARCINOGENESIS; CHLAMYDIA TRACHOMATIS; CHLAMYDIASIS; CHLAMYDOPHILA PNEUMONIAE; CHRONIC INFLAMMATION; CLOSTRIDIUM; ESCHERICHIA COLI; EUKARYOTIC CELL; EXIGUOBACTERIUM OXIDOTOLERANS; FUSOBACTERIUM; GALLBLADDER CANCER; GRAM NEGATIVE BACTERIUM; HAEMOPHILUS; HELICOBACTER INFECTION; HUMAN; INTESTINE CANCER; LUNG CANCER; MOLECULAR DYNAMICS; MOUTH CANCER; MUCOSA ASSOCIATED LYMPHOID TISSUE LYMPHOMA; MUTAGENESIS; PHARYNX CANCER; POLYMERASE CHAIN REACTION; PREVOTELLA MELANINOGENICA; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; SALMONELLA TYPHI; STAPHYLOCOCCUS AUREUS; STOMACH CARCINOMA; STREPTOCOCCUS; STREPTOCOCCUS ANGINOSUS; STREPTOCOCCUS BOVIS; STREPTOCOCCUS MITIS; SURVIVAL RATE; UTERINE CERVIX CARCINOMA; VEILLONELLA; VEILLONELLA PARVULA;

EID: 79551702757     PISSN: 09715851     EISSN: 09752129     Source Type: Journal    
DOI: 10.4103/0971-5851.76195     Document Type: Review

References (58)

1. Sugerman PB, Joseph BK, SavageNW. The role of oncogenes, tumour suppressor genes and growth factors in oral squamous cell carcinoma: A case of apoptosis versus proliferation. Oral Dis 1995;1:172-88.
2. Rodrigues VC, MossSM, Tuomainen H. Oral cancer in the UK: To screen or not to screen. Oral Oncol 1998;34:454-65. (Pubitemid 28546858)
3. World Health Organization. World Health Report. Geneva: World Health Organization; 1996.
4. Johnson N. Tobacco use and oral cancer: A global perspective. J Dent Educ 2001;65:328-39.
5. Scully C. Oral squamous cell carcinoma; from an hypothesis about a virus, to concern about possible sexual transmission. Oral Oncol 2002;38:227-34. (Pubitemid 34442543)
6. Cawson RA. Leukoplakia and oral cancer. Proc R Soc Med 1969;62:610-4.
7. Lissowska J, Pilarska A, Pilarski P, Samolczyk-Wanyura D, Piekarczyk J, Bardin-Mikollajczak A, et al. Smoking, alcohol, diet, dentition and sexual practices in the epidemiology of oral cancer in Poland. Eur J Cancer Prev 2003;12:25-33. (Pubitemid 36233019)
8. Tran N, Rose B, O'Brien CJ. Role of HPV in the etiology of Head and Neck Cancer. Head Neck Oncol 2007;29:64-70. (Pubitemid 46032569)
9. D'Costa J, Saranath D, Dedhia P, Sanghvi V, Mehta AR. Detection of HPV-16 genome in human oral cancers and potentially malignant lesions from India. Oral Oncol 1998;34:413-20. (Pubitemid 28440307)
10. Nagy KN, Sondoki I, Nagy SE, Newman HN. The microflora associated with human oral carcinomas. Oral Oncol 1998;34:304-8. (Pubitemid 28318258)
11. Hooper SJ, Crean SJ, Fardy MJ, Lewis MA, Spratt DA, Wade WG, et al. A molecular analysis of the bacteria present within oral squamous cell carcinoma. J Med Microbiol 2007;56:1651-9. (Pubitemid 350276516)
12. Ord RA, Blanchaert RH Jr. Current management of oral cancer. A multidisciplinary approach. J Am Dent Assoc 2001;132:19S-23. (Pubitemid 33741645)
13. Crowe SE. Helicobacter infection, chronic inflammation, and the development of malignancy. Curr Opin Gastroenterol 2005;1:32-8. (Pubitemid 40189221)
14. Montalban C, Santon A, Boixeda D, Bellas C. Regression of gastric high grade mucosa associated lymphoid tissue (MALT) lymphoma after Helicobacter pylori eradication. Gut 2001;49:584-7. (Pubitemid 32896991)
15. Persing DH, Prendergast FG. Infection, immunity, and cancer. Arch Pathol Lab Med 1999;123:1015-22. (Pubitemid 29526659)
16. Vaishnavi C, Kochhar R, Singh G, Kumar S, Singh S, Singh K. Epidemiology of typhoid carriers among blood donors and patients with biliary, gastrointestinal and other related diseases. Microbiol Immunol 2005;49:107-12. (Pubitemid 40364131)
17. Lax AJ, Thomas W. How bacteria could cause cancer: One step at a time. Trends Microbiol 2002;10:293-9. (Pubitemid 34671155)
18. Dutta U, Garg PK, Kumar R, Tandon RK. Typhoid carriers among patients with gallstones are at increased risk for carcinoma of the gallbladder. Am J Gastroenterol 2000;95:784-7. (Pubitemid 30123920)
19. Shukla VK, Singh H, Pandey M, Upadhyay SK, Nath G. Carcinoma of the gallbladder - is it a sequel of typhoid? Dig Dis Sci 2000;45:900-3. (Pubitemid 30238250)
20. Littman AJ, White E, Jackson LA, Thornquist MD, Gaydos CA, Goodman GE, et al. Chlamydia pneumoniae infection and risk of lung cancer. Cancer Epidemiol Biomarkers Prev 2004;13:1624-30. (Pubitemid 39331884)
21. Koyi H, Branden E, Gnarpe J, Gnarpe H, Steen B. An association between chronic infection with Chlamydia pneumoniae and lung cancer. A prospective 2-year study. APMIS 2001;109:572-80. (Pubitemid 32929731)
22. Anttila T, Koskela P, Leinonen M, Laukkanen P, Hakulinen T, Lehtinen M, et al. Chlamydia pneumoniae infection and the risk of female early-onset lung cancer. Int J Cancer 2003;107:681-2. (Pubitemid 37296134)
23. Biarc J, Nguyen IS, Pini A, Gosse F, Richert S, Thierse D, et al. Carcinogenic properties of proteins with proinflammatory activity from Streptococcus infantarius (formerly S. bovis). Carcinogenesis 2004;25:1477-84. (Pubitemid 39162714)
24. Gold JS, Bayar S, Salem RR. Association of Streptococcus bovis bacteremia with colonic neoplasia and extracolonic malignancy. neoplasia and extracolonic malignancy. Arch Surg 2004;139:760-5. (Pubitemid 38886513)
25. Ellmerich S, Scholler M, Duranton B, Gosse F, Galluser M, Klein JP, et al. Promotion of intestinal carcinogenesis by Streptococcus bovis. Carcinogenesis 2000;21:753-6. (Pubitemid 30214033)
26. Zarkin BA, Lillemoe KD, Cameron JL, Effron PN, Magnuson TH, Pitt HA. The triad of Streptococcus bovis bacteremia, colonic pathology, and liver disease. Ann Surg 1990;211:786-91.
27. Kocazeybek B. Chronic Chlamydophila pneumoniae infection in lung cancer, a risk factor: A case-control study. J Med Microbiol 2003;52:721-6. (Pubitemid 36981483)
28. Coussens LM, Werb Z. Inflammation and cancer. Nature 2002;420:860-7. (Pubitemid 36019639)
29. Parsonnet J. Bacterial infection as a cause of cancer. Environ Health Perspect 1995;103:263-8. (Pubitemid 26040912)
30. Nougayrede JP, Taieb F, De Rycke J, Oswald E. Cyclomodulins: Bacterial effectors that modulate the eukaryotic cell cycle. Trends Microbiol 2005;13:103-10. (Pubitemid 40311892)
31. Lara-Tejero M, Galán JE. A bacterial toxin that controls cell cycle progression as a deoxyribonuclease I-like protein. Science 2000;290:354-7.
32. Lax AJ. Bacterial toxins and cancer - case to answer? Nat Rev Microbiol 2005;3:343-9. (Pubitemid 40443727)
33. Pöschl G, Seitz HK. Alcohol and cancer. Alcohol Alcohol 2004;39:155-65. (Pubitemid 38578731)
34. Salaspuro MP. Acetaldehyde, microbes, and cancer of the digestive tract. Crit Rev Clin Lab Sci 2003;40:183-208. (Pubitemid 36529014)
35. Calmels S, Ohshima H, Vincent P, Gounot AM, Bartsch H. Screening of microorganisms for nitrosation catalysis at pH 7 and kinetic studies on nitrosamine formation from-secondary amines by E. coli strains. Carcinogenesis 1985;6:911-5. (Pubitemid 15064154)
36. Lijinsky W, Saavedra JE, Reuber MD, Singer SS. Esophageal carcinogenesis in F344 rats by nitrosomethylethylamines substituted in the ethyl group. J Natl Cancer Inst 1982;68:681-4. (Pubitemid 12078857)
37. Takahashi N. Acid-neutralizing activity during amino acid fermentation by Porphyromonas gingivalis, Prevotella intermedia and Fusobacterium nucleatum. Oral Microbiol Immunol 2003;18:109-13. (Pubitemid 36604365)
38. Raghunand N, Gatenby RA, Gillies RJ. Microenvironmental and cellular consequences of altered blood flow in tumours. Br J Radiol 2003;76:S11-22. (Pubitemid 39530312)
39. Sasaki H, Ishizuka T, Muto M, Nezu M, Nakanishi Y, Inagaki Y, et al. Presence of Streptococcus anginosus DNA in esophageal cancer, dysplasia of esophagus, and gastric cancer. Cancer Res 1998;58:2991-5. (Pubitemid 28335077)
40. Shiga K, Tadeda M, Saijo S, Hori T, Sato I, Tateno H, et al. Presence of Streptococcus infection in extra-oropharyngeal head and neck squamous cell carcinoma and its implication in carcinogenesis. Oncol Rep 2001;8:245-8. (Pubitemid 33758072)
41. Morita E, Narikiyo M, Yano A, Nishimura E, Igaki H, Sasaki H, et al. Different frequencies of Streptococcus anginosus infection in oral cancer and esophageal cancer. Cancer Sci 2003;94:492-6. (Pubitemid 36849711)
42. Mager DL, Haffajee AD, Devlin PM, Norris CM, Posner MR, Goodson JM. The salivary microbiota as a diagnostic indicator of oral cancer: A descriptive, non-randomized study of cancer-free and oral squamous cell carcinoma subjects. J Transl Med 2005;3:27.
43. Tsujii M, DuBois RN. Alterations in cellular adhesion and apoptosis in epithelial cells overexpressing prostaglandin endoperoxide synthase 2. Cell 1995;83:493-501.
44. Cover TL, Krishna US, Israel DA, Peek RM Jr. Induction of gastric epithelial cell apoptosis by Helicobacter pylori vacuolating cytotoxin. Cancer Res 2003;63:951-7. (Pubitemid 36278424)
45. Correa P, Miller MJ. Carcinogenesis, apoptosis and cell proliferation. Br Med Bull 1998;54:151-62. (Pubitemid 28105323)
46. Mergenhagen SE, Sandberg AL, Chassy BM, Brennan MJ, Yeung MK, Donkersloot JA, et al. Molecular basis of bacterial adhesion in the oral cavity. Rev Infect Dis 1987;9:S467-74.
47. Sojar HT, Sharma A, Genco RJ. Porphyromonas gingivalis fimbriae bind to cytokeratin of epithelial cells. Infect Immun 2002;70:96-101. (Pubitemid 34028603)
48. Khlgatian M, Nassar H, Chou HH, Gibson FC 3rd, Genco CA. Fimbria-dependent activation of cell adhesion molecule expression in Porphyromonas gingivalis-infected endothelial cells. Infect Immun 2002;70:257-67. (Pubitemid 34028626)
49. Bhavanandan VP. Cancer-associated mucins and mucin-type glycoproteins. Glycobiology 1991;1:493-503.
50. Neeser JR, Grafstrom RC, Woltz A, Brassart D, Fryder V, Guggenheim B. A 23 kDa membrane glycoprotein bearing NeuNAc alpha 2-3Gal beta 1-3GalNAc O-linked carbohydrate chains acts as a receptor for Streptococcus sanguis OMZ 9 on human buccal epithelial cells. Glycobiology 1995;5: 97-104.
51. Holmes JD, Dierks EJ, Homer LD, Potter BE. Is detection of oral and oropharyngeal squamous cancer by a dental health care provider associated with a lower stage at diagnosis? J Oral Maxillofac Surg 2003;61:285-91. (Pubitemid 36268373)
52. Richardson MA, Ramirez T, Russell NC, Moye LA. Coley toxins immunotherapy: A retrospective review. Altern Ther Health Med 1999;5:42-7.
53. Zacharski LR, Ornstein DL, Gabazza EC, D'Alessandro- Gabazza CN, Brugarolas A, Schneider J. Treatment of malignancy by activation of the plasminogen system. Semin Thromb Hemost 2002;28:5-18.
54. Niethammer AG, Xiang R, Ruehlmann JM, Lode HN, Dolman CS, Gillies SD et al. Targeted interleukin 2 therapy enhances protective immunity induced by an autologous oral DNA vaccine against murine melanoma. Cancer Res 2001;61:6178-84. (Pubitemid 32762556)
55. Niethammer AG, Xiang R, Becker JC, Wodrich H, Pertl U, Karsten G, et al. A DNA vaccine against VEGF receptor 2 prevents effective angiogenesis and inhibits tumor growth. Nat Med 2002;8:1369-75. (Pubitemid 36019421)
56. Radvanyi L. Discovery and immunologic validation of new antigens for therapeutic cancer vaccines. Int Arch Allergy Immunol 2004;133:179-97. (Pubitemid 38314651)
57. Pardoll D. Cancer vaccines. Nat Med 1998;4:525-31. (Pubitemid 28228086)
58. Niphon N. Bacteria ferry nanoparticles into cells for early diagnosis, treatment 2007.